Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Liraglutide
100%
Kidney Function
100%
Randomized Clinical Trial
100%
Short-term Effects
100%
Angiotensin II (Ang II)
40%
Type 2 Diabetic Patients
40%
Glucagon-like
40%
Receptor Agonist
40%
A1 Receptor
40%
Confidence Interval
40%
Renal Blood Flow
40%
System Components
20%
Glomerular Filtration Rate
20%
Catecholamines
20%
Tissue Perfusion
20%
Renin-angiotensin System
20%
Sodium Reabsorption
20%
Catecholamine Levels
20%
Blood Pressure
20%
Diastolic Blood Pressure
20%
51Cr-EDTA
20%
EDTA Plasma
20%
Estimated Glomerular Filtration Rate
20%
Once-daily
20%
Rate-2
20%
Atrial Natriuretic Peptide
20%
Proximal Tubular
20%
Tissue Oxygenation
20%
Blood Oxygenation
20%
Long-term Treatment
20%
Systolic Blood Pressure
20%
Renal Perfusion
20%
Placebo-controlled
20%
Heart Rate
20%
Sodium
20%
Renal Hemodynamics
20%
Male Patients
20%
Plasma Clearance
20%
Fractional Excretion
20%
Lithium
20%
Renal Protection
20%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Liraglutide
100%
Randomized Clinical Trial
100%
Kidney Function
100%
Kidney Blood Flow
60%
Angiotensin II
40%
Glomerular Filtration Rate
40%
Patient with Type 2 Diabetes
40%
Glucagon-Like Peptide-1 Agonist
40%
Catecholamine
40%
Magnetic Resonance Imaging
20%
Atrial Natriuretic Factor
20%
Diastolic Blood Pressure
20%
Systolic Blood Pressure
20%
Perfusion
20%
Renin Angiotensin Aldosterone System
20%
Single Drug Dose
20%
Chromium 51
20%
Sodium Absorption
20%
Edetic Acid
20%
Placebo
20%
Plasma Clearance
20%
Renal Protection
20%
Elevated Blood Pressure
20%
Biochemistry, Genetics and Molecular Biology
Randomized Clinical Trial
100%
Kidney Function
100%
Liraglutide
100%
Kidney Blood Flow
60%
Angiotensin
40%
Glucagon-Like Peptide 1 Receptor
40%
Catecholamine
40%
Glomerulus Filtration
40%
Receptor Agonists
40%
Magnetic Resonance Imaging
20%
Blood Pressure
20%
Plasma Clearance
20%
Atrial Natriuretic Peptide
20%
Oxygenation
20%
Single Drug Dose
20%
Diastolic Blood Pressure
20%
Tissue Oxygenation
20%
Systolic Blood Pressure
20%
Sodium Absorption
20%
Perfusion
20%
Renin Angiotensin Aldosterone System
20%
Pharmacology, Toxicology and Pharmaceutical Science
Liraglutide
100%
Non Insulin Dependent Diabetes Mellitus
100%
Randomized Clinical Trial
100%
Glucagon Like Peptide 1 Receptor Agonist
40%
Catecholamine
40%
Angiotensin II
40%
Angiotensin
20%
Placebo
20%
Ethylenediaminetetraacetic Acid
20%
Atrial Natriuretic Factor
20%
Chromium 51
20%
Elevated Blood Pressure
20%
Renin
20%